Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Xencor, Inc (XNCR), most recent 12 months reported: revenue $200.49M, net loss $117.86M, free cash flow -$176.45M. Latest balance sheet on file: liquid cash $547.73M. From SEC filings. More on Xencor, Inc: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: VANDA PHARMACEUTICALS INC. · AKEBIA THERAPEUTICS, INC. · Maravai LifeSciences Holdings, Inc. · Nuvation Bio Inc. · CRYOPORT, INC. · LIFEVANTAGE CORP · Arbutus Biopharma Corp · AMARIN CORP PLC\UK
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.